SecBot SecBot
Insider Cluster (5 insiders) ·Filed Apr 15, 2026

TVTX

Travere Therapeutics, Inc.
BEARISH
Impact 7/10
Horizonweeks Processed6mo ago
Insider cluster: 5 insiders, $3.0M total
Actionable Insight ▼ Bearish

Monitor upcoming earnings and pipeline updates closely, coordinated C-suite selling, especially by the CEO, often precedes downward revisions or clinical setbacks. Consider this a warning sign despite recent analyst optimism.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$40.95
T+0 close · Apr 14, 2026 · via day close
Latest settled
+38.19%
T+60 · $56.59
Vs SPY
+30.06%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 15 $40.95entry
  2. T+1 · 7mo ago −3.44%α −3.70% · $39.54
  3. T+5 · 7mo ago −2.10%α −3.74% · $40.09
  4. T+20 · 6mo ago +4.62%α −1.43% · $42.84
  5. T+60 · 4mo ago +38.19%α +30.06% · $56.59
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Five executives at Travere Therapeutics, including the CEO, CFO, and CMO, sold shares in a coordinated cluster totaling $2.99M over a 7-day period, with the CEO accounting for $2.33M of the total. This represents a significant insider selling event involving key C-suite leaders, suggesting potential lack of confidence in near-term prospects despite no disclosed fundamental changes.

Key Financial Metrics

Direction
selling
Total Value
$3.0M
Insiders
5

Key Facts

  • Five insiders sold a total of $2.99M in shares over 7 days
  • CEO Dube Eric M. sold 56.8K shares for $2.33M, representing 78% of total cluster value
  • All transactions were open-market sales (code S), not related to grants or tax events
  • Sales occurred at prices between $39.09 and $42.61 per share
  • Total cluster value represents ~0.08% of $3.7B market cap, modest in relative terms but highly concentrated among top executives

Financial Impact

$2.99 million in insider selling over 7 days, with $2.33M from the CEO alone

insider sentimentinvestor confidenceownership concentration

Risk Factors

  • Potential for negative clinical or regulatory news in the near term
  • Erosion of investor confidence due to concentrated executive selling
  • Possible misalignment between management and shareholder interests

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TVTX-1776974730257

Track record

21 reports on TVTX

Performance horizon

7 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +56.24% at T+60 after the Jun 2, 2026 report. 9 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $50.30 Now $49.70 −1.19% settles Nov 23
  2. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $48.87 to $51.56 Now $49.70 +1.70% ▲ +5.50% +2.21% vs SPY
  3. Nov 3, 202613d ago Institutional Cluster Bullish 4/10 Entry $49.41 to $51.99 Now $49.70 +0.59% ▲ +5.22% +5.81% vs SPY
  4. Nov 2, 202614d ago 8-K Bullish 6/10 Entry $49.41 to $51.99 Now $49.70 +0.59% ▲ +5.22% +5.81% vs SPY
  5. Sep 17, 20268w ago Insider Cluster Bearish 4/10 Entry $62.76 to $59.44 Now $49.70 +20.81% ▲ +5.29% +6.56% vs SPY
  6. Jul 9, 202618w ago 8-K Neutral 2/10 Entry $56.59 to $55.28 Now $49.70 −12.18% ▼ −2.31% −1.75% vs SPY
  7. Jun 16, 202621w ago Insider Cluster Neutral 2/10 Entry $54.14 to $57.69 Now $49.70 −8.20% ▲ +6.56% +7.60% vs SPY
  8. Jun 16, 202621w ago 8-K Neutral 2/10 Entry $54.14 to $57.69 Now $49.70 −8.20% ▲ +6.56% +7.60% vs SPY
  9. Jun 12, 202622w ago 144 Neutral 2/10 Entry $52.04 to $55.15 Now $49.70 −4.50% ▲ +5.98% +5.30% vs SPY
  10. Jun 2, 202623w ago 8-K Bullish 6/10 Entry $42.96 to $48.57 Now $49.70 +15.69% ▲ +13.06% +16.02% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 5h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 23, 2026